Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse

Placenta

Volumn 52, Issue , 2017, Pages 100-105

  Čonka, Jozef ^a   Konečná, Barbora ^a   Lauková, Lucia ^a   Vlková, Barbora ^a   Celec, Peter ^a,b  

^a Bratislava   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

Cell free DNA; Fetal hypotrophy; Fetal nucleic acid; Preeclampsia; Pregnancy complication

Indexed keywords

ALBUMIN; CREATININE; DNA; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; CELL FREE NUCLEIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FETAL HYPOTROPHY; FETUS; FETUS DISEASE; FETUS WEIGHT; HUMAN; HYPOTROPHY; LITTER SIZE; MALE; MOUSE; NONHUMAN; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PLACENTA DISORDER; PLACENTA WEIGHT; PLACENTAL HYPOTROPHY; PLACENTAL SIZE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; ANIMAL; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY;

ANIMALS; BLOOD PRESSURE; CELL-FREE NUCLEIC ACIDS; DISEASE MODELS, ANIMAL; FEMALE; LIPOPOLYSACCHARIDES; MICE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 85014684742     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2017.02.008     Document Type: Article

References (32)

1. [1] Mol, B.W.J., Roberts, C.T., Thangaratinam, S., Magee, L.A., de Groot, C.J.M., Hofmeyr, G.J., Pre-eclampsia. Lancet 387:10022 (2015), 999–1011.
2. [2] Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., Romero, R., Pre-eclampsia part 1: current understanding of its pathophysiology. Nat. Rev. Nephrol. 10:8 (2014), 466–480.
3. [3] Chaiworapongsa, T., Chaemsaithong, P., Korzeniewski, S.J., Yeo, L., Romero, R., Pre-eclampsia part 2: prediction, prevention and management. Nat. Rev. Nephrol. 10:9 (2014), 531–540.
4. [4] Lo, Y.M., Corbetta, N., Chamberlain, P.F., Rai, V., Sargent, I.L., Redman, C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350:9076 (1997), 485–487.
5. [5] Lo, Y.M.D., Chan, K.C.A., Sun, H., Chen, E.Z., Jiang, P., Lun, F.M.F., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Trans. Med., 2(61), 2010 61ra91–61ra91.
6. [6] Suzumori, N., Ebara, T., Yamada, T., Samura, O., Yotsumoto, J., Nishiyama, M., et al. Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy. J. Hum. Genet. 61:7 (2016), 647–652.
7. [7] Sifakis, S., Koukou, Z., Spandidos, D.A., Cell-free fetal DNA and pregnancy-related complications (review). Mol. Med. Rep. 11:4 (2015), 2367–2372.
8. [8] Dugoff, L., Barberio, A., Whittaker, P.G., Schwartz, N., Sehdev, H., Bastek, J.A., Cell-free DNA fetal fraction and preterm birth. Am. J. Obstet. Gynecol. 215:2 (2016), 231.e1–231.e7.
9. [9] Phillippe, M., Cell-free fetal DNA — a trigger for parturition. New Engl. J. Med. 370:26 (2014), 2534–2536.
10. [10] Vlkova, B., Turna, J., Celec, P., Fetal DNA in maternal plasma in preeclamptic pregnancies. Hypertens. Pregnancy 34:1 (2015), 36–49.
11. [11] Lo, Y.M.D., Leung, T.N., Tein, M.S.C., Sargent, I.L., Zhang, J., Lau, T.K., et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45:2 (1999), 184–188.
12. [12] Zeybek, Y.G., Gunel, T., Benian, A., Aydinli, K., Kaleli, S., Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies. J. Obstet. Gynaecol. Re 39:3 (2013), 632–640.
13. [13] Leung, T.N., Zhang, J., Lau, T.K., Chan, L.Y.S., Lo, Y.M.D., Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem. 47:1 (2001), 137–139.
14. [14] Zhong, X.Y., Holzgreve, W., Hahn, S., The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens. Pregnancy 21:1 (2002), 77–83.
15. [15] Vlkova, B., Szemes, T., Minarik, G., Turna, J., Celec, P., Circulating free fetal nucleic acids in maternal plasma and preeclampsia. Med. Hypotheses 74:6 (2010), 1030–1032.
16. [16] Scharfe-Nugent, A., Corr, S.C., Carpenter, S.B., Keogh, L., Doyle, B., Martin, C., et al. TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J. Immunol. 188:11 (2012), 5706–5712.
17. [17] Rolnik, D.L., O'Gorman, N., Fiolna, M., van den Boom, D., Nicolaides, K.H., Poon, L.C., Maternal plasma cell-free DNA in the prediction of pre-eclampsia. Ultrasound obst. Gynecol. 45:1 (2015), 106–111.
18. [18] Lazar, L., Rigó, J., Nagy, B., Balogh, K., Makó, V., Cervenak, L., et al. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med. Genet. 10:1 (2009), 1–6.
19. [19] Hartley, J.D.R., Ferguson, B.J., Moffett, A., The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia. Am. J. Obstet. Gynecol. 213:3 (2015), 268–277.
20. [20] Liu, T., Matsuguchi, T., Tsuboi, N., Yajima, T., Yoshikai, Y., Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect. Immun. 70:12 (2002), 6638–6645.
21. [21] McCarthy, C.M., Kenny, L.C., Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia?. Am. J. Reprod. Immunol., 2016, 341–347.
22. [22] Goulopoulou, S., Matsumoto, T., Bomfim, G.F., Webb, R.C., Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia. Clin. Sci. (Lond) 123:7 (2012), 429–435.
23. [23] Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:7285 (2010), 104–107.
24. [24] Di Caro, V., Walko, T.D. 3rd, Bola, R.A., Hong, J.D., Pang, D., Hsue, V., et al. Plasma mitochondrial DNA-a novel DAMP in pediatric sepsis. Shock 45:5 (2016), 506–511.
25. [25] Tsuji, N., Tsuji, T., Ohashi, N., Kato, A., Fujigaki, Y., Yasuda, H., Role of mitochondrial DNA in septic AKI via toll-like receptor 9. J. Am. Soc. Nephrol. 27:7 (2016), 2009–2020.
26. [26] Lau, T.-W., Leung, T.N., Chan, L.Y.S., Lau, T.K., Chan, K.C.A., Tam, W.H., et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin. Chem. 48:12 (2002), 2141–2146.
27. [27] Meng, W., Paunel-Gorgulu, A., Flohe, S., Witte, I., Schadel-Hopfner, M., Windolf, J., et al. Deoxyribonuclease is a potential counter regulator of aberrant neutrophil extracellular traps formation after major trauma. Mediat. Inflamm., 2012, 2012, 149560.
28. [28] Mai, S.H., Khan, M., Dwivedi, D.J., Ross, C.A., Zhou, J., Gould, T.J., et al. Delayed but not early treatment with DNase reduces organ damage and improves outcome in a murine model of sepsis. Shock 44:2 (2015), 166–172.
29. [29] Podjarny, E., Losonczy, G., Baylis, C., Animal models of preeclampsia. Semin. Nephrol. 24:6 (2004), 596–606.
30. [30] Xue, P., Zheng, M., Gong, P., Lin, C., Zhou, J., Li, Y., et al. Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia. PLoS One, 10(4), 2015, e0124001.
31. [31] Konecna, B., Borbelyova, V., Celec, P., Vlkova, B., Does rat fetal DNA induce preeclampsia in pregnant rats?. J. Dev. Orig. Health Dis. 6:1 (2015), 5–9.
32. [32] Silver, R.M., Myatt, L., Hauth, J.C., Leveno, K.J., Peaceman, A.M., Ramin, S.M., et al. Cell-free total and fetal DNA in first trimester maternal serum and subsequent development of preeclampsia. Am. J. Perinat., 2016, 191–198.